Translate
Kalvista Pharmaceuticals Inc
About
Kalvista Pharmaceuticals Inc (NASDAQ:KALV) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 30 2026
KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference
Mar 25 2026
KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
Mar 20 2026
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference
Mar 18 2026
KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026
Recent Videos
Cómo invertir en KalVista Pharmaceuticals Inc (KALV) paso a paso
Mar 11, 2026
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Receives $29.17 Average Price Target from Brokerages
Jan 20, 2026
KALV STOCK : POTENTIAL UPSIDE | KALVISTA PHARMACEUTICALS STOCK
Jan 04, 2026
My Take on KalVista's Convertible Note Strategy
Oct 02, 2025
Financials
Revenue
$73.62 M
Market Cap
$1.02 B
EPS
-3.94